- Editor's PickSeana Smith•23 hours ago
Yahoo Finance is tracking the stocks you’re following, based on your Yahoo Finance ticker searches.
- Market Realist•17 minutes ago
AstraZeneca is reducing its selling, general, and administrative expenses for better profitability. Its R&D costs will be in line with 2015.
- Market Realist•2 hours ago
AstraZeneca's (AZN) oncology segment is another key focus area. The segment’s contribution increased to more than 15% in 2Q16.
AstraZeneca PLC (AZN)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||33.38 x 1600|
|Ask||33.39 x 2700|
|Day's Range||33.25 - 33.42|
|52wk Range||26.97 - 35.04|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||38.18|
|Avg Vol (3m)||6,165,301|
|Dividend & Yield||0.90 (2.66%)|